1. People's Republic of China Stocks

  2. •

    Basic Materials

  3. •

    Chemicals - Specialty
COFCO Biotechnology Co., Ltd.

COFCO Biotechnology Co., Ltd.

000930.SZ
COFCO Biotechnology Co., Ltd.CN flagShenzhen Stock Exchange
4.39
CNY
-0.11
- -
8.15BMarket Cap
COFCO Biotechnology Co., Ltd.
000930.SZ
(Shenzhen Stock Exchange)

Recent

price

4.39

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
6.2
7.67
8.03
7.67
7.51
6.69
5.81
8.55
9.53
10.54
10.77
12.78
10.73
11.07
10.77
9.45
6.76
Revenue per Share
0.31
0.37
0.19
0.05
0.04
-1.47
0.13
0.5
0.26
0.32
0.32
0.61
0.57
-0.33
0.01
0.02
-0.05
Basic EPS, GAAP
0.14
0.56
0.11
0.52
0.08
-0.21
0.65
0.46
-0.96
1.49
-2.11
2.02
0.08
0.72
-0.18
0.63
-0.29
Free Cash Flow per Basic Share
0.21
0.21
0.22
0.19
0.17
0.19
0.14
0.42
0.1
0.11
0.09
0.15
0.3
0.64
0.05
0.04
0.03
Dividend per Share
1.46
1.75
1.82
1.85
1.86
0.35
0.48
0.54
1.27
1.59
1.9
2.42
2.7
1.78
1.76
1.82
1.75
Book Value per Share
2.37
2.74
2.8
2.86
2.9
1.28
1.42
2.52
4.54
4.89
5.18
5.84
6.21
5.37
5.34
5.41
5.29
Tangible Book Value per Share
963
965
963
957
952
965
964
1,859
1,858
1,847
1,848
1,844
1,857
1,842
1,861
1,854
1,857
Basic Weighted Avg Shares
5,967
7,401
7,730
7,340
7,153
6,457
5,603
15,892
17,704
19,472
19,909
23,560
19,918
20,379
20,053
17,512
12,556
Sales/Revenue/Turnover
-5.18
1.47
1.38
0.69
1.2
-9.49
2.95
7.83
7.82
8.25
6.14
7.93
8.53
0.6
2.88
2.82
2.39
Operating Margin (%)
250
260
242
257
272
276
168
613
609
425
436
450
458
492
507
517
- -
Depreciation Expense
294
355
183
51
35
-1,418
127
929
483
593
593
1,130
1,059
-602
25
38
-96
Net Income, GAAP
17.79
27.48
23.99
6.78
47.11
- -
1.95
13.59
16.26
16.13
21.67
18
22.01
- -
64.68
44.01
30.39
Effective Tax Rate (%)
4.92
4.8
2.37
0.69
0.49
-21.96
2.27
5.85
2.73
3.04
2.98
4.79
5.31
-2.95
0.13
0.22
-0.76
Profit Margin (%)
-1,846
-1,149
-840
-962
-819
-1,150
-1,113
-4,444
-398
219
570
2,046
2,509
894
973
1,101
1,015
Working Capital
414
373
853
779
688
564
378
535
646
275
311
524
297
362
342
526
669
LT Debt
2,659
2,996
3,069
3,093
3,104
1,574
1,706
5,957
9,694
10,228
10,802
11,755
12,510
10,854
10,916
11,015
10,805
Total Equity
-4.26
1.35
1.38
0.8
0.78
- -
3.69
14.93
9
9.34
6.15
9.26
8.54
- -
1.36
1.91
- -
Return on Invested Capital (%)
8.44
10.11
6.44
4.02
2.48
- -
8.28
22.84
8.28
10.23
7.35
13.19
13.33
- -
0.54
1.1
1.52
Return on Capital (%)
22.76
22.91
10.62
2.88
1.99
-134.34
31.73
127.32
28.78
22.4
18.41
28.33
22.33
-14.51
0.77
1.15
-2.91
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
1,907
2,565
LT Borrowings
- -
368
509
LT Finance Leases
- -
158
160
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
- -
1,856
1,856
Market Capitalization
11,062
10,728
12,534

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
- -
6,120
6,997
Cash, Cash Equivalents & STI
- -
2,488
1,817
Accounts Receivable, Net
- -
823
1,229
Inventories
- -
1,886
2,780
Total Current Liabilities
- -
5,019
5,981
Payables & Accruals
- -
- -
- -
ST Debt
- -
1,907
2,565
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
33.49%
0.7%
0.9%
Free Cash Flow
-123.33%
-9.46%
-458.34%
Net Income, GAAP
37.29%
-24.84%
52.68%
Sales/Revenue/Turnover
18.49%
-1.82%
-12.67%
Total Cash Common Dividend
55.13%
35.38%
-11.14%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
4,732
5,179
5,213
4,929
20,053
2025
4,385
4,427
- -
4,250
17,512
2026
3,879
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
- -
- -
- -
0.01
2025
0.02
- -
- -
- -
0.02
2026
-0.07
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
- -
- -
- -
0.05
2025
0.01
- -
- -
- -
0.04
2026
0.01
- -
- -
- -
- -
Similar Companies
Zhejiang Xinhua Chemical Co.,Ltd (603867.SS)
Kanchi Karpooram Ltd (KANCHI.BO)
Orient Ceratech Limited (ORIENTCER.BO)
Zhejiang Bofay Electric Co.,Ltd. (001255.SZ)
Shanxi Tond Chemical Co., Ltd. (002360.SZ)
Xpro India Limited (XPROINDIA.NS)
Business
COFCO Biotechnology Co., Ltd. (000930.SZ) engages in corn deep processing and biotechnology innovation, producing food ingredients, bioenergy, and biodegradable materials from high-quality corn sourced from Northeast China's Golden Corn Belt. The company offers starch, modified starch, glucose syrup, monosodium glutamate, citric acid, fuel ethanol, edible alcohol, alcohol disinfectant solution, polylactic acid, vitamin E, phytosterol, lactide, PHA, and D-allulose; it operates through food ingredients, bioenergy, and biomass materials segments. COFCO Biotechnology maintains over 20 subsidiaries across Heilongjiang, Jilin, Tianjin, Hebei, Anhui, Shanghai, Hubei, Sichuan, Guangxi, and Thailand, serving domestic and international markets with a processing capacity of around 7 million tons of corn annually. Founded in 1998 and headquartered in Bengbu, Anhui Province, China, the company, a subsidiary of COFCO Group, listed on the Shenzhen Stock Exchange in 1999 and changed its name from COFCO Biochemical (Anhui) Co., Ltd. in September 2019. COFCO Biotechnology recently launches D-allulose products in September 2025 for food applications including beverages, dairy, and baking; establishes a new biotechnology subsidiary, Anhui COFCO Biotechnology Co., Ltd., with 250 million yuan registered capital for bio-based materials research, polymerization, and manufacturing; and approves construction of starch sugar and allulose production facilities as of December 2025.